MOH vs. CNC, HUM, ALGN, ARGX, WAT, GMAB, TEVA, BNTX, COO, and ALNY
Should you be buying Molina Healthcare stock or one of its competitors? The main competitors of Molina Healthcare include Centene (CNC), Humana (HUM), Align Technology (ALGN), argenx (ARGX), Waters (WAT), Genmab A/S (GMAB), Teva Pharmaceutical Industries (TEVA), BioNTech (BNTX), Cooper Companies (COO), and Alnylam Pharmaceuticals (ALNY). These companies are all part of the "medical" sector.
Centene (NYSE:CNC) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, community ranking, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.
Molina Healthcare has a net margin of 2.99% compared to Molina Healthcare's net margin of 1.76%. Centene's return on equity of 29.86% beat Molina Healthcare's return on equity.
Centene received 486 more outperform votes than Molina Healthcare when rated by MarketBeat users. Likewise, 73.25% of users gave Centene an outperform vote while only 56.91% of users gave Molina Healthcare an outperform vote.
93.6% of Centene shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 0.3% of Centene shares are owned by company insiders. Comparatively, 1.1% of Molina Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Centene has higher revenue and earnings than Molina Healthcare. Centene is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.
In the previous week, Centene had 1 more articles in the media than Molina Healthcare. MarketBeat recorded 19 mentions for Centene and 18 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 0.84 beat Centene's score of 0.77 indicating that Centene is being referred to more favorably in the media.
Centene currently has a consensus price target of $85.23, suggesting a potential upside of 9.19%. Molina Healthcare has a consensus price target of $404.90, suggesting a potential upside of 16.48%. Given Centene's higher possible upside, analysts plainly believe Molina Healthcare is more favorable than Centene.
Centene has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Comparatively, Molina Healthcare has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500.
Summary
Molina Healthcare beats Centene on 10 of the 18 factors compared between the two stocks.
Get Molina Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for MOH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MOH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Molina Healthcare Competitors List
Related Companies and Tools
